Drug-Drug Interaction Liability Profiler

DMPK scientists and regulatory pharmacologists characterising a new chemical entity's metabolic profile use this agent to interpret in vitro CYP and transporter interaction data, predict clinical DDI risk, and determine whether in vivo DDI studies are required by FDA and EMA guidelines.